ATEZOLIZUMAB - BEVACIZUMAB in the Treatment Hepatocellular Carcinoma Inoperable or

Clinical trial NCT04730388 · UNKNOWN

Trial details

NCT number: NCT04730388
Sponsor: University Hospital, Brest
Status: UNKNOWN
Study type: OBSERVATIONAL

Advanced Hepatocellular Carcinoma

Start date: 2021-01-18
Primary completion: 2022-01-18
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.